- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT05985538
Impacto das mensagens de prevenção do cigarro eletrônico em adolescentes
The purpose of this trial is to determine whether a vaping prevention text message program reduces susceptibility to vaping among adolescents and young adults. This study addresses this issue by exposing participants to a vaping prevention text message program over a 28-day period in a randomized controlled trial with a matched attention control condition. A follow-up assessment is also made 4 weeks after the text messaging ends.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Tobacco prevention communication is a key tool for reducing tobacco use among adolescents and young adults. While the use of e-cigarettes and vaping has increased greatly among adolescents and young adults, there has been a dearth of research on effective communication strategies to reduce vaping. This study will test the impact of a text-messaging program on reducing susceptibility to vaping in a randomized controlled trial, illuminating whether such programs can be effective. The investigators focus on adolescents and young adults (ages 13-20) who currently vape or who are at risk of vaping.
Participants will be randomly assigned to receive either a vaping prevention text message program or a wellness text message program (control). Participants in the study will take 4 online surveys over an 8-week period - at Visit 1 (baseline), Visit 2 (2 weeks), Visit 3 (4 weeks), and Visit 4 (8 weeks).
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
North Carolina
-
Chapel Hill, North Carolina, Estados Unidos, 27599
- University of North Carolina, Chapel Hill
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Ages 13-20 years old (inclusive)
- Have a phone that sends and receives text messages
- Ever vaped or are susceptible to using e-cigarettes or vaping
Exclusion Criteria:
- None
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Vaping prevention text messages
Participants will receive text messages (2 daily, on average) about the harms of e-cigarette use and vaping for 28 days, with introductory messages sent on day 1 and concluding messages sent on day 28. |
Participants will receive text messages (2 daily, on average) about the harms of e-cigarette use and vaping for 28 days, with introductory messages sent on day 1 and concluding messages sent on day 28. Each vaping prevention text message will focus on one of six topics: nicotine addiction, monetary costs of vaping, chemical exposures from e-cigarette vapor, cosmetic effects of vaping, mental and physical use symptoms of vaping, and health impact on organs from vaping. Some text messages will ask participants for a reply (i.e., two-way messages). |
|
Comparador Ativo: Wellness behavior text messages
Participants will receive text messages (2 daily, on average) about general wellness topics, with introductory messages sent on day 1 and concluding messages sent on day 28. |
Participants will receive text messages (2 daily, on average) about general wellness topics, with introductory messages sent on day 1 and concluding messages sent on day 28. Each wellness text message will focus on one of six topics: sleep hygiene, safe driving, sun safety, study habits, nutrition, and exercise. This attention control condition is matched with the intervention condition in that participants will receive the same number of text messages over the same number of days, the same intervention structure (e.g., 6 topics), and the same number and types of two-way messages. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Mean Susceptibility to Vaping Score
Prazo: Visit 3 (4 weeks)
|
The mean susceptibility to vaping score will be assessed using the questionnaire. Response options are on a 1 to 4 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-4), with higher scores representing a greater susceptibility to vaping (a worse outcome). |
Visit 3 (4 weeks)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Mean Vaping Instrumental Attitudes Score
Prazo: Visit 3 (4 weeks)
|
The mean vaping instrumental attitudes score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a belief that vaping is more beneficial, safe and healthy. |
Visit 3 (4 weeks)
|
|
Mean Vaping Affective Attitudes Score
Prazo: Visit 3 (4 weeks)
|
.The mean vaping affective attitudes score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a belief that vaping is more enjoyable, pleasant, and fun. |
Visit 3 (4 weeks)
|
|
Mean Vaping Addiction Risk Beliefs Score
Prazo: Visit 3 (4 weeks)
|
The mean vaping addiction risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing more tendency to addiction. |
Visit 3 (4 weeks)
|
|
Mean Vaping Monetary Cost Beliefs Score
Prazo: Visit 3 (4 weeks)
|
The mean vaping monetary cost beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represents participants' believes that vaping is a costly activity. |
Visit 3 (4 weeks)
|
|
Mean Vaping Chemical Risk Beliefs Score
Prazo: Visit 3 (4 weeks)
|
The mean vaping chemical risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing participant's believes that e-cigarette vapor contains chemicals that pose health risks. |
Visit 3 (4 weeks)
|
|
Mean Vaping Cosmetic Risk Beliefs Score
Prazo: Visit 3 (4 weeks)
|
The mean vaping cosmetic risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing participant belief that use will harm their cosmetic appearance. |
Visit 3 (4 weeks)
|
|
Mean Vaping Health Symptoms Beliefs Score
Prazo: Visit 3 (4 weeks)
|
The mean vaping physical symptoms of use beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represent participant believes that e-cigarette use will cause certain physical symptoms. |
Visit 3 (4 weeks)
|
|
Mean Vaping Mental Health Symptoms of Use Beliefs Score
Prazo: Visit 3 (4 weeks)
|
The mean vaping mental health symptoms of use beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represent participant believes that e-cigarette use will cause or worsen mental health symptoms. |
Visit 3 (4 weeks)
|
|
Mean Vaping Health Organ Risk Beliefs Score
Prazo: Visit 3 (4 weeks)
|
The mean vaping health organ risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing participant believes that e-cigarette use will harm the health of certain organs. |
Visit 3 (4 weeks)
|
|
Mean Susceptibility to Smoking Cigarettes Score
Prazo: Visit 3 (4 weeks)
|
The mean susceptibility to smoking cigarettes score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represent participant more open to smoking. |
Visit 3 (4 weeks)
|
|
Mean Smoking Instrumental Attitude Score
Prazo: Visit 3 (4 weeks)
|
The 1-item mean smoking instrumental attitude measure assesses a participant's attitude toward smoking. Response options are on a 1 to 5 scale, with higher scores representing a more harmful perception of smoking. |
Visit 3 (4 weeks)
|
|
Mean Smoking Affective Attitude Score
Prazo: Visit 3 (4 weeks)
|
The 1-item mean smoking affective attitude measure assesses a participant's attitude toward smoking (unenjoyable/enjoyable). Response options are on a 1 to 5 scale, with higher scores representing a more enjoyable attitude toward smoking. |
Visit 3 (4 weeks)
|
|
Mean Smoking Addiction Risk Belief Score
Prazo: Visit 3 (4 weeks)
|
The 1-item mean smoking addiction risk belief measure assesses the extent to which a participant believes that smoking will lead to addiction. Response options are on a 1 to 5 scale, with higher scores representing beliefs that smoking will lead to addiction. |
Visit 3 (4 weeks)
|
|
Mean Smoking Health Harm Risk Belief Score
Prazo: Visit 3 (4 weeks)
|
The 1-item mean smoking health harm risk belief measure assesses the extent to which a participant believes that smoking will lead to health harm. Response options are on a 1 to 5 scale, with higher scores representing higher beliefs that smoking will cause to health harm. |
Visit 3 (4 weeks)
|
|
Mean Vaping Injunctive Norms Score
Prazo: Visit 3 (4 weeks)
|
The 3-item mean vaping injunctive norms scale assesses a participant's perception of others' approval or disapproval of their vaping behavior. Response options are on a 1 to 5 scale. Overall scores are determined by summing the scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a participant's perception of others' approval about vaping. |
Visit 3 (4 weeks)
|
|
Mean Vaping Refusal Self-efficacy Score
Prazo: Visit 3 (4 weeks)
|
The 3-item mean vaping refusal self-efficacy scale assesses a participant's confidence that they could refuse to vape in a social situation. Response options are on a 1 to 5 scale. Overall scores are determined by summing the scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a higher amount of refuse to vape in a social situation. |
Visit 3 (4 weeks)
|
|
Frequency of Vaping
Prazo: Visit 3 (4 weeks)
|
Participants will be asked the number of days they vaped over the past 30 days, with higher scores indicating more days vaped. |
Visit 3 (4 weeks)
|
|
Frequency of Cigarette Smoking
Prazo: Visit 3 (4 weeks)
|
Participants will be asked the number of days they smoked cigarettes over the past 30 days, with higher scores indicating more days smoked. |
Visit 3 (4 weeks)
|
|
Frequency of Using Other Tobacco Products
Prazo: Visit 3 (4 weeks)
|
Participants will be asked if they used other tobacco products (OTP) over the past 30 days. OTP use will be determined as follows: no use = person who doesn't use OTPs; used = person who uses OTPs; no response = person who skipped or refused to answer |
Visit 3 (4 weeks)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Seth Noar, PhD, UNC Lineberger Comprehensive Cancer Center
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 20-1245
- 5R01DA049155-02 (Concessão/Contrato do NIH dos EUA)
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .